[e-drug] GTPI petition against the FTA between European Union and India

e-drug
1

E-DRUG: GTPI petition against the FTA between European Union and India
-----------------------------------------------------------

In light of the meeting with members of the International Trade Commission of the European Parliament, scheduled for April 9th at the office of the Brazilian Interdisciplinary AIDS Association, the Working Group of Intellectual Property (GTPI) decided to promote a on-line petition (in Portuguese and English) as form of protest against the negotiations of the Free Trade Agreement (FTA) between India and European Union. Such agreement could significantly harm access to medicines to combat HIV and AIDS in developing countries. (Click here to better understand better the case: http://www.abiaids.org.br/noticias/destaqueView.aspx?lang=pt&seq=12788)

Those interested in signing the petition can access http://www.petitiononline.com/ftaIndia/petition.html.
The document will be delivered to members of the European Parliament and to the Ambassador of India in Brazil. The deadline for signatures is the 8th of April.

Renata Reis
Brazil
"Renata Reis" <renata@abiaids.org.br>

2

E-DRUG: GTPI petition against the FTA between European Union & India (2)
-----------------------------------------------------------
[Attachments are not possible on E-drug. If you would like a copy of the article and can't find it from the title given, please contact Donald Light <dlight@princeton.edu>]

I'm glad to hear of the protest, and you should know there is a new article that details how the EU was persuaded (or rather politically engineered) to grant 10 years of data exclusivity, which largely harms middle- and low-income countries, without any evidence that it would increase innovation. It appears in the Nov 2009 issue of the Journal of Health Politics, Policy and Law, vol 46, n0. 3: 979-1010 and is titled "Policy Making on Data Exclusivity in the European Union." The first author is Adamini, S, and I will attached a copy here.

In August 2009, the first article was published documenting the reduced access to vital medicines, in Health Affairs web exclusive.

Donald

Donald Light
Princeton UNiversity
Cell: 609-216-0071
Donald Light <dlight@princeton.edu>